Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Antiviral Research
|
April 19, 2024
An allosteric inhibitor of sirtuin 2 blocks hepatitis B virus covalently closed circular DNA establishment and its transcriptional activity
Liudi Tang, Stacy Remiszewski, Andrew Snedeker, et al.
Novartis Foundation Symposium
|
June 3, 2004
Molecular and cellular basis for the anti-proliferative effects of the HDAC inhibitor LAQ824
Peter Atadja, Meier Hsu, Paul Kwon, et al.
The Journal of Biological Chemistry
|
May 24, 2025
Structural basis for sirtuin 2 activity and modulation: Current state and opportunities
Samuel P Bernhard, Francesc X Ruiz, Stacy Remiszewski, et al.
Antiviral Research
|
August 10, 2023
Inhibition of SIRT2 promotes death of human cytomegalovirus-infected peripheral blood monocytes via apoptosis and necroptosis
Jennifer Cheung, Stacy Remiszewski, Lillian W Chiang, et al.
Haematologica
|
April 13, 2004
Use of a novel histone deacetylase inhibitor to induce apoptosis in cell lines of acute lymphoblastic leukemia
Annette Romanski, Biserka Bacic, Gesine Bug, et al.
The Journal of Organic Chemistry
|
October 24, 2001
Highly Regioselective Nitration Reactions Provide a Versatile Method of Functionalizing Benzocycloheptapyridine Tricyclic Ring Systems: Application toward Preparation of Nanomolar Inhibitors of Farnesyl Protein Transferase
F. George Njoroge, Bancha Vibulbhan, Patrick Pinto, et al.
Blood
|
June 21, 2003
NVP-LAQ824 is a potent novel histone deacetylase inhibitor with significant activity against multiple myeloma
Laurence Catley, Ellen Weisberg, Yu-Tzu Tai, et al.
Cancer Research
|
January 28, 2004
Selective growth inhibition of tumor cells by a novel histone deacetylase inhibitor, NVP-LAQ824
Peter Atadja, Lin Gao, Paul Kwon, et al.
Acta Crystallographica. Section D, Biological Crystallography
|
September 4, 2013
The structure of XIAP BIR2: understanding the selectivity of the BIR domains
Christine Lukacs, Charles Belunis, Robert Crowther, et al.
The Journal of Clinical Investigation
|
June 15, 2023
An allosteric inhibitor of sirtuin 2 deacetylase activity exhibits broad-spectrum antiviral activity
Kathryn L Roche, Stacy Remiszewski, Matthew J Todd, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Antiviral Research
|
April 19, 2024
An allosteric inhibitor of sirtuin 2 blocks hepatitis B virus covalently closed circular DNA establishment and its transcriptional activity
Liudi Tang, Stacy Remiszewski, Andrew Snedeker, et al.
Novartis Foundation Symposium
|
June 3, 2004
Molecular and cellular basis for the anti-proliferative effects of the HDAC inhibitor LAQ824
Peter Atadja, Meier Hsu, Paul Kwon, et al.
The Journal of Biological Chemistry
|
May 24, 2025
Structural basis for sirtuin 2 activity and modulation: Current state and opportunities
Samuel P Bernhard, Francesc X Ruiz, Stacy Remiszewski, et al.
Antiviral Research
|
August 10, 2023
Inhibition of SIRT2 promotes death of human cytomegalovirus-infected peripheral blood monocytes via apoptosis and necroptosis
Jennifer Cheung, Stacy Remiszewski, Lillian W Chiang, et al.
Haematologica
|
April 13, 2004
Use of a novel histone deacetylase inhibitor to induce apoptosis in cell lines of acute lymphoblastic leukemia
Annette Romanski, Biserka Bacic, Gesine Bug, et al.
The Journal of Organic Chemistry
|
October 24, 2001
Highly Regioselective Nitration Reactions Provide a Versatile Method of Functionalizing Benzocycloheptapyridine Tricyclic Ring Systems: Application toward Preparation of Nanomolar Inhibitors of Farnesyl Protein Transferase
F. George Njoroge, Bancha Vibulbhan, Patrick Pinto, et al.
Blood
|
June 21, 2003
NVP-LAQ824 is a potent novel histone deacetylase inhibitor with significant activity against multiple myeloma
Laurence Catley, Ellen Weisberg, Yu-Tzu Tai, et al.
Cancer Research
|
January 28, 2004
Selective growth inhibition of tumor cells by a novel histone deacetylase inhibitor, NVP-LAQ824
Peter Atadja, Lin Gao, Paul Kwon, et al.
Acta Crystallographica. Section D, Biological Crystallography
|
September 4, 2013
The structure of XIAP BIR2: understanding the selectivity of the BIR domains
Christine Lukacs, Charles Belunis, Robert Crowther, et al.
The Journal of Clinical Investigation
|
June 15, 2023
An allosteric inhibitor of sirtuin 2 deacetylase activity exhibits broad-spectrum antiviral activity
Kathryn L Roche, Stacy Remiszewski, Matthew J Todd, et al.
Page
of 2